Protest AFR No. 3195-04-100142; Polypeptides; 9817.85.01 Prototype Treatment; Additional U.S. Rule of Interpretation 1(b); Actual Use; 19 CFR 10.134; Classification
Reasoning
Protest AFR No. 3195-04-100142; Polypeptides; 9817.85.01 Prototype Treatment; Additional U.S. Rule of Interpretation 1(b); Actual Use; 19 CFR 10.134; Classification
Cite this ruling
CBP Ruling W563169 (29332935): Protest AFR No. 3195-04-100142; Polypeptides; 9817.85.01 Prototype Treatment; Additional U.S. Rule of Interpretation 1(b); Actual Use; 19 CFR 10.134; Classification
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293329
The tariff classification of Teceleukin [Recombinant Human Interleukin-2 (rIL-2)] (CAS-94218-75-4), imported in bulk form, from China
The tariff classification of 2-Hydroxyethylethylene Urea (CAS 3699-54-5) from China.
The tariff classification of 2-Mercapto-1-Methylimidazole (CAS 60-56-0) from China.
The tariff classification of Ondansetron (CAS-116002-70-1), imported in bulk form, from China
The tariff classification of Miconazole Nitrate, USP (CAS-22832-87-7), imported in bulk form, from Italy